Stem cell therapy is a regulated option for MS in Thailand, primarily utilizing Mesenchymal Stem Cells (MSCs). While the Thai Food and Drug Administration (TFDA) oversees these treatments, they are often used as supportive regenerative care alongside standard disease-modifying therapies in Bangkok and Phuket clinics.
- Regulated types: Clinics mainly use umbilical cord-derived Mesenchymal Stem Cells (UC-MSCs) for immunomodulatory effects.
- Treatment timeframe: Protocols typically require 5 to 14 days for assessment and cell administration.
- Accreditation standards: Top facilities maintain AABB-certified laboratories or Joint Commission International (JCI) accreditation.
- Cost comparison: Procedures in Thailand average $3,000 to $6,000, saving approximately 76% versus US costs.
Bookimed Expert Insight: While many private clinics focus on UC-MSC infusions, high-volume centers like Bumrungrad International Hospital serve 1,000,000 patients annually by integrating advanced neurology with regenerative options. Choosing a hospital with JCI and GHA credentials ensures international safety standards that smaller, boutique stem cell clinics may not provide.
Patient Consensus: Patients emphasize the need for transparency regarding long-term results and suggest consulting a home neurologist before traveling. Many recommend verifying if clinic claims are backed by entries in clinical trial registries or PubMed.